Affymax, Inc.
Affymax, Inc., officials detail recent developments
Published in Hospital Business Week, July 22nd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Affymax, Inc.
Report 1: Affymax, Inc. (Nasdaq:AFFY) announced results to date from two separate Phase 2 clinical trials of Hematide(TM) in dialysis and non-dialysis chronic kidney disease (CKD) patients. The data showed that in treatment naive, non-dialysis patients Hematide could correct anemia when administered monthly at an appropriate dose. Similarly, the data in dialysis patients previously treated with three-times weekly Epoetin Alfa demonstrated that mean hemoglobin (Hgb) levels could be...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- Aging
Ed Koch, Bob Weiner Urge Home Care Alternatives to Nursing Homes; Seek Congress Address 'Silent Sadness of Seniors' Forced Unnecessarily to Leave Own Homes - Angiology
Village Court Contributes to a Healthy Community With Complimentary Artery Screening - Anpath Group Inc.
Anpath Group, Inc. Announces New Distribution Partner in Korea - Antifungals
Bioalliance Pharma Licenses Loramyc U.s. Commercialization Rights To Par Pharmaceutical In a $65 Million Deal - Assurant Health
Insurance Executive: Let's Not Force Consumers to Play Roulette When Buying Basic Health Services - Atrial Fibrillation
deCODE Discovers a Variation in the Sequence of the Genome Conferring Risk of Atrial Fibrillation - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
